Basel, 29 April 2015
Invitation to Roche Analyst Event at ASCO 2015
We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group's oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (29 May - 2 June 2015).
Marriott Downtown Chicago
Chicago A-D (Level 5)
540 North Michigan Avenue
Sunday, 31 May 2015
6:45pm to 8:30pm Central Daylight Time CDT (Chicago)
followed by a buffet reception.
Download to my calendar (download to your calendar will be in local time Chicago)
- Working along the cancer immunity-cycle: Strategies and new agents
Ira Mellman, gRED: Ph.D., Vice President, Cancer Immunology, Genentech
William Pao, pRED: M.D., Ph.D., Global Head Oncology Discovery and Translational Area, Roche
- ASCO 2015 Roche highlights: Growing importance of combinations
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development
- Growing importance of molecular information
Garret Hampton, Ph.D., Vice President, Oncology Biomarker Development and Companion Diagnostics
- Oncology strategy and outlook
Daniel O'Day, Chief Operating Officer Roche Pharmaceuticals
- Date: 31 May 2015
- Time (CDT):
6:15pm Registration desk opens
6:45pm Start of meeting
8:30pm End of meeting followed by a buffet reception
To register for the event, please follow the link (Password: Analyst2015)
Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
- +41 (0) 58 310 5000 (Europe and ROW) or
- +44 (0) 203 059 5862 (UK) or
- +1 (1) 631 570 5613 (USA)
To expedite the registration process on the day of the conference call, you may pre-register for the event. click here.
Alternatively a live audio webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.com following to the closure of the ASCO meeting.
A replay will be available as of 8:30am CEST/7:30am BST on 1 June for 48 hours. Access is by dialing:
- +41 (0) 91 612 4330 (Europe and ROW) or
- +44 (0) 207 108 6233 (UK) or
- +1 (1) 631 982 4566 (USA)
Please enter the conference ID 10468 followed by the # sign.
A replay of the webcast will be available on demand on the Roche website. click here.